Airway epithelial Fas ligand expression: Potential role in modulating bronchial inflammation

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 274, Issue 3 18-3, 1998, Pages

  Gochuico, Bernadette R ^a   Miranda, Kathleen M ^a   Hessel, Edith M ^b   De Bie, Joris J ^b   Van Oosterhout, Antoon J M ^b   Cruikshank, William W ^a   Fine, Alan ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Apoptosis; Asthma; Clara cell; gld mouse; Lung

Indexed keywords

ALLERGEN; FAS ANTIGEN; LIGAND; OVALBUMIN;

ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; ASTHMA; BRONCHUS; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY CELL; LUNG ALVEOLUS EPITHELIUM; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0031943598     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1998.274.3.l444     Document Type: Article

References (29)

1. Bellgrau, D., D. Gold, H. Selawry, J. Moore, A. Franzusoff, and R. C. Duke. A role for CD95 ligand in preventing graft rejection. Nature 377: 630-632, 1995.
2. Blyth, D. I., M. S. Pedrick, T. J. Savage, E. M. Hessel, and D. Fattah. Lung inflammation and epithelial changes in a murine model of atopic asthma. Am. J. Respir. Cell Mol. Biol. 14: 425-438, 1996.
3. Breel, M., M. Van der Ende, T. Sminia, and G. Kraal. Subpopulations of lymphoid and non-lymphoid cells in bronchus-associated lymphoid tissue (BALT) of the mouse. Immunology 63: 657-662, 1988.
4. Cohen, P. L., and R. A. Eisenberg. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9: 243-269, 1991.
5. Enari, M., R. V. Talanian, W. W. Wong, and S. Nagata. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380: 723-726, 1996.
6. Erjefalt, J. S., F. Sundler, and C. G. A. Persson. Eosinophils, neutrophils, and venular gaps in the airway mucosa at epithelial removal-restitution. Am. J. Respir. Crit. Care Med. 153: 1666-1674, 1996.
7. Fine, A., N. L. Anderson, T. L. Rothstein, M. C. Williams, and B. R. Gochuico. Fas expression in pulmonary alveolar type II cells. Am. J. Physiol. 273 (Lung Cell. Mol. Physiol. 17): L64-L71, 1997.
8. French, L. E., M. Hahne, I. Viard, G. Radlgruber, R. Zanone, K. Becker, C. Muller, and J. Tschopp. Fas and Fas ligand in embryos and adult mice: ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell Biol. 133: 335-343, 1996.
9. Griffith, T. S., T. Brunner, S. M. Fletcher, D. R. Green, and T. A. Ferguson. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270: 1189-1192, 1995.
10. Hahne, M., D. Rimoldi, M. Schroter, P. Romero, M. Schreier, L. E. French, P. Schneider, T. Bornand, A. Fontana, D. Lienard, J. C. Cerottini, and J. Tschopp. Melanoma cell expression of Fas (Apo-1/CD95) ligand: implications for tumor immune escape. Science 274: 1363-1366, 1996.
11. Hanabuchi, S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. Yagita, and K. Okumura. Fas and its ligand in a general mechanism of T cell-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA 91: 4930-4934, 1994.
12. Hessel, E. M., A. J. M. Van Oosterhout, I. Van Ark, B. Van Esch, G. Hofman, H. Van Loveren, H. F. Savelkoul, and F. P. Nijkamp. Development of airway hyperresponsiveness is dependent on interferon-gamma and independent of eosinophil infiltration. Am. J. Respir. Cell Mol. Biol. 16: 325-334, 1997.
13. Holt, P. G., and C. McMenamin. Defense against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin. Exp. Allergy 19: 255-262, 1989.
14. Ibraghimov, A. R., and R. G. Lynch. T cell specialization at environmental interfaces: T cells from the lung and the female genital tract of lpr and gld mice differ from their splenic and lymph node counterparts. Eur. J. Immunol. 24: 1848-1852, 1994.
15. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233-243, 1991.
16. Ju, S. T., H. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. Fas (CD95)/ FasL interactions required for programmed cell death after T cell activation. Nature 373: 444-448, 1995.
17. Kayagaki, N., N. Yamaguchi, F. Nagao, S. Matsuo, H. Maeda, K. Okumura, and H. Yagita. Polymorphism of murine Fas ligand that affects the biological activity. Proc. Natl. Acad. Sci. USA 94: 3914-3919, 1997.
18. Lynch, D. L., M. L. Watson, M. R. Alderson, P. R. Baum, R. E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C. A. Smith, K. Hunter, D. Bhat, W. Din, R. G. Goodwin, and M. F. Seldin. The mouse Fas-ligand gene is mutated in gld mice and is part of a TNF family gene cluster. Immunity 1: 131-136, 1994.
19. Massaro, G. D., G. Singh, R. Mason, C. G. Plopper, A. M. Malkinson, and D. B. Gail. Biology of the Clara cell. Am. J. Physiol. 266 (Lung Cell. Mol. Physiol. 10): L101-L106, 1994.
20. Mysler, E., P. Bini, J. Drappa, P. Ramos, S. M. Friedman, P. H. Krammer, and K. B. Elkon. The apoptosis-1/Fas protein in human systemic lupus erythematosus. J. Clin. Invest. 93: 1029-1034, 1994.
21. Niehans, G. A., T. Brunner, S. P. Frizelle, J. C. Liston, C. T. Salerno, D. J. Knapp, D. R. Green, and R. A. Kratzke. Human lung carcinomas express Fas ligand. Cancer Res. 57: 1007-1012, 1997.
22. Ogasawara, J., R. Watanabe-Fukunaga, A. Adachi, M. Matsuzawa, T. Kasugai, Y. Kitamura, N. Itoh, T. Suda, and S. Nagata. Lethal effect of the anti-Fas antibody in mice. Nature 364: 806-809, 1993.
23. Panoskaltsis-Mortari, A., and R. P. Bucy. In situ hybridization with digoxigenin RNA probes: facts and artifacts. Biotechniques 18: 300-307, 1995.
24. Rieux-Laucat, F., F. Le Deist, C. Hivroz, I. A. G. Roberts, K. M. Debatin, A. Fischer, and J. P. De Villartay. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349, 1995.
25. Sayama, K., S. Yonehara, Y. Watanabe, and Y. Miki. Expression of Fas antigen in keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J. Invest. Dermatol. 103: 330-334, 1994.
26. Suda, T., T. Takahashi, P. Golstein, and S. Nagata. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178, 1993.
27. Tsuyuki, S., C. Bertrand, F. Erard, A. Trifilieff, J. Tsuyuki, M. Wesp, G. P. Anderson, and A. J. Coyle. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J. Clin. Invest. 96: 2924-2931, 1995.
28. Vaux, D. L., and A. Strasser. The molecular biology of apoptosis. Proc. Natl. Acad. Sci. USA 93: 2239-2244, 1996.
29. Watanabe-Fukunaga, R., C. I. Brannan, N. Itoh, S. Yonehara, N. G. Copeland, N. A. Jenkins, and S. Nagata. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148: 1274-1279, 1992.